Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Regarding the PTSC Annual SHM held on 1/28/2010
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I take it then your preference is to cut overhead to the max and distribute all earnings to shareholders.

Actually what you say with respect to share buy backs seems to sound right. Is there any arguments for share buybacks that should be considered?

Opty

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply